Tissue Damage in Radiation-Induced Oral Mucositis Is Mitigated by IL-17 Receptor Signaling

Oral mucositis (OM) is a treatment-limiting adverse side effect of radiation and chemotherapy. Approximately 80% of patients undergoing radiotherapy (RT) for head and neck cancers (HNC) develop OM, representing a major unmet medical condition. Our understanding of the immunopathogenesis of OM is lim...

Descripción completa

Detalles Bibliográficos
Autores principales: Saul-McBeth, Jessica, Dillon, John, Lee, Aaron, Launder, Dylan, Kratch, Jacqueline M., Abutaha, Eanas, Williamson, Alexandria A., Schroering, Allen G., Michalski, Grace, Biswas, Priosmita, Conti, Samuel R., Shetty, Amol C., McCracken, Carrie, Bruno, Vincent M., Parsai, E. Ishmael, Conti, Heather R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248500/
https://www.ncbi.nlm.nih.gov/pubmed/34220843
http://dx.doi.org/10.3389/fimmu.2021.687627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248500/
https://www.ncbi.nlm.nih.gov/pubmed/34220843
http://dx.doi.org/10.3389/fimmu.2021.687627

Ejemplares similares